References

Home • AltMed Home • Search • Feedback

 

 

 

History
Mechanism of Action
Clinical Studies
Safety
Dosage
Conclusions
References
Links

 

 

REFERENCES

Barclay TS, Tsourounis C, McCart GM. Glucosamine. The Annals of Pharmacotherapy 1998; 32:574-79.

Bruyere O, Honore A, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Correlation between radiographic severity of knee osteoarthritis and future diseases progression.  Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis & Cartilage 2003; 11:1-5.

Camara CC, Dowless GV. Glucosamine sulfate for osteoarthritis. The Annals of Pharmacotherapy 1998; 32:580-587.

Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheumatological Disease Clinics of North America 1999; 25: 379-95.

Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of osteoarthritis of the knee. Journal of Rheumatology 1999;2423-30.

McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for the treatment of osteoarthritis. A systemic quality assessment and Meta-analysis. JAMA 15 March 2000; 283: 1469-75.

Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Archives of Internal Medicine 2002; 162: 2113-2123.

Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune F, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Long-term effects of glucosamine sulfate on osteoarthritis progression: A randomized, placebo-controlled clinical trial. Lancet 2001; 357: 251-256.

Richy F, Bruyere O, Ethgen, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. Archives of Internal Medicine 2003; 163: 1514-1522.

Runkel DR, Cupp MJ. Glucosamine sulfate use in osteoarthritis. American Journal of Health-System Pharmacy 1 Feb 1999; 56: 267-69.

Talent JM, Gracey RW. Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clinical Therapeutics 1996; 18: 1184-1189.

Towheed TE. Current status of glucosamine therapy in osteoarthritis. Arthritis and Rheumatism 2003; 49:601-604.